Retrospective study of the relationship between the effects of immunotherapy and background factors such as BMI in patients with advanced / recurrent non-small cell lung cancer

Retrospective study of the relationship between the effects of immunotherapy and background factors such as BMI in patients with advanced / recurrent non-small cell lung cancer - Retrospective study of the relationship between the effects of immunotherapy and background factors such as BMI in patients with advanced / recurrent non-small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043305

Enrollment

150

Registered

2021-02-12

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients that diagnosed as advanced / recurrent non-small cell lung cancer, and received immunotherapy at our hospital

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A patient diagnosed as advanced / recurrent non-small cell lung cancer. A patient in which immunotherapy (immune checkpoint inhibitor alone or combined immunotherapy using a combination of immune checkpoint inhibitor and chemotherapy) was performed in our hospital.

Exclusion criteria

Exclusion criteria: A patient in which information on background factors such as effects and BMI cannot be collected

Design outcomes

Primary

Measure	Time frame
Relationship between overall survival and pretreatment BMI	—

Countries

Japan

Contacts

Public ContactNaruo Yoshimura

Tohoku Medical and Pharmaceutical University, Faculty of Medicine Division of Respiratory Medicine

y-naruo@sc4.so-net.ne.jp0222908850

Outcome results